GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (LTS:0NM7) » Definitions » Valuation Rank

Virbac (LTS:0NM7) Valuation Rank


View and export this data going back to 2008. Start your Free Trial

What is Virbac Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Virbac Valuation Rank Related Terms

Thank you for viewing the detailed overview of Virbac's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac (LTS:0NM7) Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.